Long-term results of iris-claw phakic intraocular lens implantation for the correction of high myopia: 5 year follow-up

Session Details

Session Title: Presented Poster Session: Refractive Surgery New Techniques/Instrumentation/Devices III

Venue: Poster Village: Pod 2

First Author: : M.Al Dreihi GERMANY

Co Author(s): :    H. Alfhaily   A. Anbari                    

Abstract Details

Purpose:

To report the 5-year refractive results and endothelial cell loss after iris-claw phakic intraocular lens (IOL) implantation to correct high myopia, and to compare our results with other studies

Setting:

Mouassat University Hospital, Damascus University, Syria

Methods:

A prospective interventional clinical study was carried out. 44 eyes of 27 patients underwent implantation of iris-claw phakic IOL (Ophtec BV, Groningen, the The Netherlands) to correct high myopia. Outcome measures included the uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), endothelial cell loss and complications

Results:

Patients were followed for 5 years postoperatively. Postoperative UDVA was ≥ 0.5 in 65% of eyes, ≥ 0.8 in 34.3% of eyes and ≥ 1.0 in 19.8% of eyes at last follow up. Postoperative CDVA was ≥ 0.5 in 86.2% of eyes, ≥ 0.8 in 51.6% of eyes, ≥ 1.0 in 34.7% of eyes and ≥ 1.2 in 20.5% of eyes at last follow up. Mean endothelial cell loss was 3.3% at last follow up. No major intraoperative or postoperative complications were noted

Conclusions:

Implantation of iris-claw phakic IOL offers good outcomes, efficacy and safety. The 5-year endothelial cell loss in our study is comparable with other international studies

Financial Disclosure:

None